— Michael Saylor, MicroStrategy
Strategy needs to pay $689M a year to not sell bitcoin
Strategy has to pay $689M to not sell any of its BTC, and those costs have increased every quarter since 2021.
Results for Michael Saylor, MicroStrategy
152 stories, newest first
— Michael Saylor, MicroStrategy
STRE is nothing like what Michael Saylor promised on Thursday
Strategy founder Michael Saylor repeatedly promised a roll-out of STRC counterparts but instead he launched STRE.
— Michael Saylor, MicroStrategy
Strategy diluted MSTR by $54M but only bought $46M of bitcoin
Strategy diluted shareholders by $69.5M but bought $45.6M of BTC. These 183,501 extra shares accreted less than the proceeds to its treasury.
— Michael Saylor, MicroStrategy
Strategy earnings puts tiny STRC front and center
Strategy released its Q3 earnings yesterday, spending vast amounts of time on its newest, (and relatively small) preferred stock, STRC.
— Michael Saylor, MicroStrategy
What to expect on Strategy’s Q3 earnings call today
Strategy is reporting earnings today after the market close. Here are the top seven things investors expect to learn.
CHART: mNAV down across bitcoin treasury companies
The premium that investors are paying for BTC treasury companies continues to decline. In other words, mNAV compression is real.
— Michael Saylor, MicroStrategy
Strategy hasn’t sold any STRC through ATM since July
Michael Saylor has been particularly optimistic about expanding STRC domestically and abroad, yet his STRC ATM sales to date are $0.
— Michael Saylor, MicroStrategy
Strategy fails to list options on its flagship preferred, STRK
Options are trading for every type of share at Michael Saylor’s Strategy, except for the company’s first and most bullish preferred share.
MSTR outperformed bitcoin on just 22 days in the past year
MSTR investors have grown accustomed to outperforming BTC, but they've actually underperformed it for 90% of the past year.
— Michael Saylor, MicroStrategy
Michael Saylor was selling MSTR ahead of S&P 500 decision
Strategy was selling hundreds of millions of dollars worth of MSTR ahead of the company’s disappointing S&P 500 Index news.